This inventor holds 2 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignee: Leo-Pharma A/s. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Kim Troensegaard Nielsen: Innovator in Calcimimetic Compounds
Introduction
Kim Troensegaard Nielsen is a notable inventor based in Jyllinge, Denmark. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of calcimimetic compounds. With a total of 2 patents to his name, Nielsen's work is recognized for its innovative approaches to drug formulation.
Latest Patents
Nielsen's latest patents focus on the polymorphic forms of a calcimimetic compound. The first patent describes the crystalline, polymorphic Form C of the compound {4-[(1R,3S)-3-((R)-1-Naphthalen-1-yl-ethylamino)-cyclopentyl]-phenoxy}-acetic acid. This invention includes methods of preparation and characterization using advanced techniques such as single crystal X-Ray crystallography, X-Ray Powder diffractometry, and Solid State NMR spectroscopy. The second patent details the crystalline, polymorphic Form X of the same compound, outlining its preparation through crystallization and precipitation methods.
Career Highlights
Kim Troensegaard Nielsen is currently employed at Leo-Pharma A/S, where he continues to advance his research in pharmaceutical innovations. His work has contributed to the understanding and application of calcimimetic compounds in medical treatments.
Collaborations
Nielsen collaborates with esteemed colleagues, including Tanja Maria Greve and Søren Ebdrup, who share his commitment to advancing pharmaceutical science.
Conclusion
Kim Troensegaard Nielsen is a distinguished inventor whose work in calcimimetic compounds has the potential to impact the pharmaceutical industry significantly. His innovative patents and collaborations reflect his dedication to advancing medical science.